Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Intellia Therapeutics (NTLA) Q4 2023 Earnings
NTLA
+4.71%
22
Feb
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.5
-1.39
-1.28
-1.17
Details
Expected EPS
-1.43845
Actual EPS
-1.46
Surprise EPS
-0.02
Surprise Percent
+1.5%
Description
Intellia Therapeutics (NTLA) has reported earnings of -1.46 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login